Results 191 to 200 of about 98,812 (291)

Anlotinib in combination with docetaxel for advanced nonsmall cell lung cancer after failure of platinum‐based treatment: A phase 1/2 trial

open access: yesCancer, Volume 131, Issue 10, 15 May 2025.
Abstract Background The combination of anlotinib with chemotherapy has demonstrated encouraging efficacy in the treatment of nonsmall cell lung cancer (NSCLC). The objective of this phase 1/2 trial was to establish the maximum tolerated dose of anlotinib in combination with docetaxel and to assess the efficacy and safety of this regimen in patients ...
Jiawei Shou   +11 more
wiley   +1 more source

A novel explanation for the reduced LDL cholesterol in severe hypertriglyceridemia.

open access: hybrid, 1989
Anne Minnich   +2 more
openalex   +1 more source

Troglitazone (CS-045) normalizes hypertriglyceridemia and restores the altered patterns of glucose-stimulated insulin secretion in dyslipidemic rats [PDF]

open access: green, 2000
Adriana Chicco   +5 more
openalex   +1 more source

Elevated pancreatic glucagon in moderately obese patients. Relationship of fatty liver and hypertriglyceridemia.

open access: bronze, 1989
Toshiki Inokuchi   +4 more
openalex   +2 more sources

Apolipoprotein E2 (Lys146→Gln) Causes Hypertriglyceridemia due to an Apolipoprotein E Variant–Specific Inhibition of Lipolysis of Very Low Density Lipoproteins–Triglycerides [PDF]

open access: bronze, 2000
Femke de Beer   +9 more
openalex   +1 more source

Resistant Hypertriglyceridemia in a Patient With High Plasma Levels of Apolipoprotein CII [PDF]

open access: bronze, 2000
Paolo Fornengo   +4 more
openalex   +1 more source

Severe hypertriglyceridemia is primarily polygenic.

open access: yesJournal of Clinical Lipidology, 2019
J. Dron   +10 more
semanticscholar   +1 more source

A systematic review of the epidemiology and risk factors for severity and recurrence of hypertriglyceridemia-induced acute pancreatitis. [PDF]

open access: yesBMC Gastroenterol
Lu J   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy